| # | Drug | Count |
|---|---|---|
| 0 | LISINOPRIL | 27 |
| 1 | AMLODIPINE | 20 |
| 2 | ASPIRIN | 18 |
| 3 | ASPIRIN 325 MG | 18 |
| 4 | ASPIRIN 81 MG | 18 |
| 5 | FUROSEMIDE | 17 |
| 6 | GABAPENTIN | 16 |
| 7 | METHOTREXATE SODIUM | 16 |
| 8 | BEVACIZUMAB | 15 |
| 9 | CYCLOSPORINE | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 1 | BAXDROSTAT | 1 | 0.0037 |
| 2 | MILRINONE LACTATE | 1 | 0.0036 |
| 3 | PAMABROM | 1 | 0.0027 |
| 4 | I. V. FAT EMULSION | 1 | 0.0014 |
| 5 | TEDIZOLID PHOSPHATE | 1 | 0.0012 |
| 6 | VERICIGUAT | 1 | 0.0010 |
| 7 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 1 | 0.0010 |
| 8 | METAXALONE | 3 | 0.0009 |
| 9 | MARAVIROC | 2 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 45 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 2 | Dihydropyridine Calcium Channel Blocker [EPC] | 24 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 23 |
| 4 | beta-Adrenergic Blocker [EPC] | 22 |
| 5 | Calcium Channel Blocker [EPC] | 20 |
| 6 | Kinase Inhibitor [EPC] | 19 |
| 7 | Loop Diuretic [EPC] | 19 |
| 8 | Benzodiazepine [EPC] | 18 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 1 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 2 | Nonergot Dopamine Agonist [EPC] | 6 | 0.0004 |
| 3 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 4 | Cannabinoid [EPC] | 3 | 0.0004 |
| 5 | Recombinant Human Growth Hormone [EPC] | 7 | 0.0003 |
| 6 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 7 | Progesterone [EPC] | 7 | 0.0003 |
| 8 | Androgen [EPC] | 8 | 0.0003 |
| 9 | Carnitine Analog [EPC] | 1 | 0.0003 |